Amgen Names Joshua Ofman Vice President, Reimbursement and Payment Policy.THOUSAND OAKS, Calif. -- Amgen Inc. (Nasdaq:AMGN), the world's largest biotechnology company, today announced the appointment of Joshua Ofman, M.D., M.S.H.S., to the new position of vice president, Reimbursement and Payment Policy. As of today, Ofman will be responsible for the design and execution of Amgen's reimbursement and payment strategy and will help to ensure the integration of reimbursement needs into the product development and commercialization process. "Josh is an acknowledged physician expert in health economics and a respected member of the health care policy world," said David Beier, Amgen's senior vice president, Global Government Affairs. "In this new role, Josh is leading the effort to ensure that patients have access to Amgen's products and that payors, especially governments, understand the value proposition that our products represent." Ofman joined Amgen in 2003 as senior director, U.S. Medical Affairs, and head of Amgen's U.S. Health Economics and Outcomes Research group. Prior to joining Amgen, Ofman was an academic gastroenterologist at Cedars-Sinai Health System and senior vice president of Zynx Health, Inc., a subsidiary of Cerner Corp., a publicly traded healthcare information technology company. Ofman obtained his undergraduate degree from the University of California at Berkeley (body, education) University of California at Berkeley - (UCB) See also Berzerkley, BSD. http://berkeley.edu/. Note to British and Commonwealth readers: that's /berk'lee/, not /bark'lee/ as in British Received Pronunciation. and his M.D. from the University of California The University of California has a combined student body of more than 191,000 students, over 1,340,000 living alumni, and a combined systemwide and campus endowment of just over $7.3 billion (8th largest in the United States). , Irvine College of Medicine. He conducted his internship and residency in internal medicine, and fellowship in digestive diseases at the University of California, Los Angeles UCLA comprises the College of Letters and Science (the primary undergraduate college), seven professional schools, and five professional Health Science schools. Since 2001, UCLA has enrolled over 33,000 total students, and that number is steadily rising. (UCLA UCLA University of California at Los Angeles UCLA University Center for Learning Assistance (Illinois State University) UCLA University of Carrollton, TX and Lower Addison, TX ) Department of Medicine. In addition, Ofman completed a RAND/VA/UCLA fellowship in ambulatory care ambulatory care n. Medical care provided to outpatients. ambulatory care, n the health services provided on an outpatient basis to those who can visit a health care facility and return home the same day. and health services research Health services research is the multidisciplinary field of scientific investigation that studies how social factors, financing systems, organizational structures and processes, health technologies, and personal behaviors affect access to health care, the quality and cost of health care, , specializing in technology assessment, and received a Masters of Science in Health Services from the UCLA School of Public Health The UCLA School of Public Health is the graduate school of public health affiliated with UCLA, and is located within the Center for Health Sciences building on the UCLA campus. UCLA is located in the Westwood neighborhood of Los Angeles, California. . Amgen is a global biotechnology company that discovers, develops, manufactures and markets important human therapeutics based on advances in cellular and molecular biology and medicinal chemistry. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion